Peripheral blood monocyte and T‐lymphocyte activation levels at diagnosis predict long‐term survival in head and neck squamous cell carcinoma patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0463|123|4|305-314

ISSN： 0903-4641

Source： APMIS (ELECTRONIC), Vol.123, Iss.4, 2015-04, pp. : 305-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV‐positive head and neck squamous cell carcinoma

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 5, 2015-05 ,pp. : 630-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2704-2712

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck

By  

Case Reports in Oncology, Vol. 8, Iss. 3, 2015-11 ,pp. : 503-508

Karger

Access to resources Recommend Favorite

Long‐term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3‐decade survey

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1608-1619

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Squamous Cell Carcinoma of the Head and Neck

By  

Oncology Research and Treatment, Vol. 25, Iss. 3, 2002-07 ,pp. : 208-212

Karger

Access to resources Recommend Favorite